Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide.

Etcheverry A, Aubry M, Idbaih A, Vauleon E, Marie Y, Menei P, Boniface R, Figarella-Branger D, Karayan-Tapon L, Quillien V, Sanson M, de Tayrac M, Delattre JY, Mosser J.

PLoS One. 2014 Sep 18;9(9):e104455. doi: 10.1371/journal.pone.0104455. eCollection 2014.

PMID:
25233099
[PubMed - in process]
Free PMC Article
2.

A case of a generalized lichenoid tattoo reaction.

Jacks SK, Zirwas MJ, Mosser JL.

J Clin Aesthet Dermatol. 2014 Aug;7(8):48-50.

PMID:
25161761
[PubMed]
Free PMC Article
3.

Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.

Collet B, Avril T, Aubry M, Hamlat A, Le Reste PJ, Chiforeanu D, Vauleon E, Mosser J, Quillien V.

J Proteomics. 2014 Aug 1;110C:7-19. doi: 10.1016/j.jprot.2014.07.022. [Epub ahead of print]

PMID:
25088051
[PubMed - as supplied by publisher]
4.

Nasopharyngeal carriage and transmission of Streptococcus pneumoniae in American Indian households after a decade of pneumococcal conjugate vaccine use.

Mosser JF, Grant LR, Millar EV, Weatherholtz RC, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL.

PLoS One. 2014 Jan 17;9(1):e79578. doi: 10.1371/journal.pone.0079578. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e93878.

PMID:
24465365
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients.

Quillien V, Lavenu A, Sanson M, Legrain M, Dubus P, Karayan-Tapon L, Mosser J, Ichimura K, Figarella-Branger D.

J Neurooncol. 2014 Feb;116(3):487-96. doi: 10.1007/s11060-013-1332-y. Epub 2014 Jan 14.

PMID:
24420923
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms.

Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J.

J Mol Diagn. 2014 Jan;16(1):45-55. doi: 10.1016/j.jmoldx.2013.07.009. Epub 2013 Oct 30.

PMID:
24183959
[PubMed - indexed for MEDLINE]
7.

Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas.

de Tayrac M, Saikali S, Aubry M, Bellaud P, Boniface R, Quillien V, Mosser J.

PLoS One. 2013 Sep 11;8(9):e73332. doi: 10.1371/journal.pone.0073332. eCollection 2013.

PMID:
24039914
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Mortality and long-term virologic outcomes in children and infants treated with lopinavir/ritonavir.

Estripeaut D, Mosser J, Doherty M, Acosta W, Shah H, Castaño E, Luciani K, Pascale JM, Bollinger RC, Page KR.

Pediatr Infect Dis J. 2013 Dec;32(12):e466-72. doi: 10.1097/INF.0b013e3182a09276.

PMID:
23799516
[PubMed - in process]
9.

Immune genes are associated with human glioblastoma pathology and patient survival.

Vauléon E, Tony A, Hamlat A, Etcheverry A, Chiforeanu DC, Menei P, Mosser J, Quillien V, Aubry M.

BMC Med Genomics. 2012 Sep 14;5:41. doi: 10.1186/1755-8794-5-41.

PMID:
22980038
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

U.S. EPA response to the Fukushima Daiichi Nuclear Power Plant accident.

Tupin EA, Boyd MA, Mosser JE, Wieder JS.

Health Phys. 2012 May;102(5):563-9. doi: 10.1097/HP.0b013e31824cc02e.

PMID:
22469933
[PubMed - indexed for MEDLINE]
11.

Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells.

Doyard M, Fatih N, Monnier A, Island ML, Aubry M, Leroyer P, Bouvet R, Chalès G, Mosser J, Loréal O, Guggenbuhl P.

Osteoporos Int. 2012 Oct;23(10):2435-45. doi: 10.1007/s00198-011-1871-z. Epub 2012 Jan 12.

PMID:
22237814
[PubMed - indexed for MEDLINE]
12.

Isolation of a new cell population in the glioblastoma microenvironment.

Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, Michalak S, François P, Carré JL, Mosser J; Grand Ouest Glioma Project Network, Menei P.

J Neurooncol. 2012 Feb;106(3):493-504. doi: 10.1007/s11060-011-0701-7. Epub 2011 Sep 18.

PMID:
21928115
[PubMed - indexed for MEDLINE]
13.

Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.

Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V.

Brain Pathol. 2012 Mar;22(2):159-74. doi: 10.1111/j.1750-3639.2011.00515.x. Epub 2011 Sep 16.

PMID:
21790828
[PubMed - indexed for MEDLINE]
14.

5q12.1 deletion: delineation of a phenotype including mental retardation and ocular defects.

Jaillard S, Andrieux J, Plessis G, Krepischi AC, Lucas J, David V, Le Brun M, Bertola DR, David A, Belaud-Rotureau MA, Mosser J, Lazaro L, Treguier C, Rosenberg C, Odent S, Dubourg C.

Am J Med Genet A. 2011 Apr;155A(4):725-31. doi: 10.1002/ajmg.a.33758. Epub 2011 Mar 15.

PMID:
21594994
[PubMed - indexed for MEDLINE]
15.

Mechanisms of immunomodulation in human glioblastoma.

Avril T, Vauleon E, Tanguy-Royer S, Mosser J, Quillien V.

Immunotherapy. 2011 Apr;3(4 Suppl):42-4. doi: 10.2217/imt.11.39. Review.

PMID:
21524170
[PubMed - indexed for MEDLINE]
16.

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.

Collet B, Guitton N, Saïkali S, Avril T, Pineau C, Hamlat A, Mosser J, Quillien V.

Proteome Sci. 2011 Apr 6;9(1):16. doi: 10.1186/1477-5956-9-16.

PMID:
21470419
[PubMed]
Free PMC Article
17.

[MGMT analysis in gliomas].

Quillien V, Vauléon E, Saikali S, Lesimple T, Hamlat A, Etcheverry A, Mosser J.

Bull Cancer. 2011 Mar;98(3):291-303. doi: 10.1684/bdc.2011.1332. Review. French.

PMID:
21459716
[PubMed - indexed for MEDLINE]
18.

A 4-gene signature associated with clinical outcome in high-grade gliomas.

de Tayrac M, Aubry M, Saïkali S, Etcheverry A, Surbled C, Guénot F, Galibert MD, Hamlat A, Lesimple T, Quillien V, Menei P, Mosser J.

Clin Cancer Res. 2011 Jan 15;17(2):317-27. doi: 10.1158/1078-0432.CCR-10-1126. Epub 2011 Jan 11.

PMID:
21224364
[PubMed - indexed for MEDLINE]
Free Article
19.

DNA methylation in glioblastoma: impact on gene expression and clinical outcome.

Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, Quillien V, Mosser J.

BMC Genomics. 2010 Dec 14;11:701. doi: 10.1186/1471-2164-11-701.

PMID:
21156036
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation.

Dubourg C, Sanlaville D, Doco-Fenzy M, Le Caignec C, Missirian C, Jaillard S, Schluth-Bolard C, Landais E, Boute O, Philip N, Toutain A, David A, Edery P, Moncla A, Martin-Coignard D, Vincent-Delorme C, Mortemousque I, Duban-Bedu B, Drunat S, Beri M, Mosser J, Odent S, David V, Andrieux J.

Eur J Med Genet. 2011 Mar-Apr;54(2):144-51. doi: 10.1016/j.ejmg.2010.11.003. Epub 2010 Nov 20.

PMID:
21094706
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk